CONMED ( NYSE:CNMD – Get Rating ) updated its second quarter 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.77-$0.82 for the period, compared to the consensus estimate of $0.79. The company issued revenue guidance of $300.00 million-$310.00 million, compared to the consensus revenue estimate of $301.46 million. CONMED also updated its FY 2023 guidance to $3.30-$3.50 EPS. Analysts Set New Price Targets Several research analysts recently commented on CNMD shares.

https://www.dailypolitical.com/2023/04/30/conmed-nysecnmd-releases-q2-2023-earnings-guidance.html

#dailypolitical